Skip to main content

Benznidazole FDA Approval History

Last updated by Judith Stewart, BPharm on Sep 7, 2020.

FDA Approved: Yes (First approved August 29, 2017)
Generic name: benznidazole
Dosage form: Tablets
Company: Chemo Research, S. L.
Treatment for: Trypanosomiasis

Benznidazole is an antiprotozoal indicated for the treatment of Chagas disease, or American trypanosomiasis, a parasitic infection caused by Trypanosoma cruzi.

Development timeline for benznidazole

Aug 29, 2017Approval FDA Approves Benznidazole as First U.S. Treatment for Chagas Disease
Jun 27, 2017Benznidazole IND for Chagas Disease Receives Clearance by FDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.